EUVIMEDEUVIMED entdecken
Crossref

Multi‐Regional Comprehensive Genomic Profiling of Diffuse‐Type Cholangiocarcinoma in Five Patients

Keita Sonoda iD, Hideyuki Hayashi iD, Yuta Abe iD, Kohei Nakamura iD, Yasushi Hasegawa iD, Shutaro Hori, Masayuki Tanaka iD, Yutaka Nakano iD, Hiroshi Nishihara, Yuko Kitagawa

Journal of Hepato-Biliary-Pancreatic Sciences · 05.11.2026

DOI: 10.1002/jhbp.70201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 05.11.2026. Verfasst von Keita Sonoda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Keio University School of Medicine, Tokyo, Japan. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Purpose Differentiating between the monoclonal spread of a single tumor and multicentric carcinogenesis in perihilar cholangiocarcinoma (PHC) with multiple nodules is a major clinical challenge. The clonal origins of these multifocal tumors remain unclear. This study used multi‐regional comprehensive genomic profiling (CGP) to investigate its biological basis.

Methods

We retrospectively identified 5 patients with extensive PHC and multiple nodules from 175 resected cases. Fourteen spatially distinct tumor nodules were collected from surgical specimens. Each underwent CGP using a 216‐gene panel to compare driver gene alterations and assess clonal relationships.

Results

Multi‐regional analysis revealed a monoclonal origin in 4 of 5 cases, with identical driver mutations in KRAS , TP53 , and ARID1A across nodules within each patient. One case was a polyclonal tumor (a possible collision‐type process), with distinct mutation profiles ( TP53 / BRAF vs. KDM6A / SMARCA4 ) in separate nodules.

Conclusions

In this five‐patient series, four tumors were monoclonal, likely spreading via intraductal seeding or intramural metastasis, whereas one was a polyclonal tumor not reliably distinguished by pathology alone. Although routine multi‐regional genomic analysis is not yet feasible, these hypothesis‐generating findings suggest two distinct biological pathways and require validation in larger cohorts.

Schlagwörter

Stichwörter der Autor:innen

clonal relationshipcomprehensive genomic profilingmulticentric carcinogenesispolyclonal tumortumor heterogeneity

Autor:innen und Institutionen

  • Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan.
  • David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Keita Sonoda, Hideyuki Hayashi, Yuta Abe, Kohei Nakamura, Yasushi Hasegawa, Masayuki Tanaka, Yutaka Nakano

Zitieren

APA

Sonoda, K., Hayashi, H., Abe, Y., Nakamura, K., Hasegawa, Y., Hori, S., Tanaka, M., Nakano, Y., Nishihara, H., & Kitagawa, Y. (2026). Multi‐Regional Comprehensive Genomic Profiling of Diffuse‐Type Cholangiocarcinoma in Five Patients. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70201

Vancouver

Sonoda K, Hayashi H, Abe Y, Nakamura K, Hasegawa Y, Hori S, et al. Multi‐Regional Comprehensive Genomic Profiling of Diffuse‐Type Cholangiocarcinoma in Five Patients. Journal of Hepato-Biliary-Pancreatic Sciences. 2026. doi:10.1002/jhbp.70201

BibTeX
@article{Sonoda2026,
  author = {Sonoda, Keita and Hayashi, Hideyuki and Abe, Yuta and Nakamura, Kohei and Hasegawa, Yasushi and Hori, Shutaro and Tanaka, Masayuki and Nakano, Yutaka and Nishihara, Hiroshi and Kitagawa, Yuko},
  title = {Multi‐Regional Comprehensive Genomic Profiling of Diffuse‐Type Cholangiocarcinoma in Five Patients},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2026},
  doi = {10.1002/jhbp.70201}
}
Kostenlos starten →